Bill Commons

MN SF 3822

died on adjournment

Use of prior authorization and step therapy prohibition for drugs used in the treatment of opioid use disorder under medical assistance

Minnesota · 2025-2026 · upper

Follow this bill’s action updates (Atom)

Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.

Quick answers

Did MN SF 3822 pass?

No. MN SF 3822 died when the 2025-2026 session adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2026-02-23): Referred to Health and Human Services

What is MN SF 3822 about?

MN SF 3822 is a bill in the 2025-2026 titled “Use of prior authorization and step therapy prohibition for drugs used in the treatment of opioid use disorder under medical assistance”.

Who sponsors MN SF 3822?

Fateh is the primary sponsor of MN SF 3822.

Introduced
2026-02-23
Latest action
2026-02-23 — Referred to Health and Human Services
Bill type
bill
Last updated
—

Subjects

Sponsors

  • Fatehprimary

Committees

Not provided by source.

Action timeline

Newest first

  1. 2026-02-23

    Referred to Health and Human Services

    referral-committee

  2. 2026-02-23

    Introduction and first reading

    introduction

Versions

Documents

Votes

Not provided by source.

Related bills

Official source

Attribution

Data from openstates_api_sync, retrieved 2026-09-29T04:24:42.271813Z

Inspect retained evidence for changes recorded after evidence tracking began:

Session-wide evidence can include changes to other bills:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=MN&identifier=SF 3822. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.

See the methodology page for data sources and limitations.